Analysis Article • 19h
Have your own idea? Try our Stock Screener
German (DAX) Pharma Industry Analysis
UpdatedJun 16, 2026
DataAggregated Company Financials
Companies9
- 7D-1.4%
- 3M2.2%
- 1Y21.5%
- YTD4.1%
Over the last 7 days, the Pharma industry has dropped 1.4%, driven by a pullback from Merck KGaA of 4.4%. Over the past 12 months, the industry was up 21%. As for the next few years, earnings are expected to grow by 22% per annum.
Industry Valuation and Performance
Has the German Pharma Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Wed, 17 Jun 2026 | €96.5b | €67.4b | €482.5m | 22.8x | 200x | 1.4x |
| Fri, 15 May 2026 | €93.2b | €67.4b | €511.2m | 19x | 182.3x | 1.4x |
| Sun, 12 Apr 2026 | €91.1b | €67.9b | -€883,890,069.56 | 18.3x | -103x | 1.3x |
| Tue, 10 Mar 2026 | €86.6b | €67.9b | -€900,313,674.29 | 17.8x | -96.2x | 1.3x |
| Thu, 05 Feb 2026 | €100.8b | €68.3b | €2.9b | 17.3x | 35.2x | 1.5x |
| Sat, 03 Jan 2026 | €93.1b | €68.3b | €2.9b | 17.9x | 32.5x | 1.4x |
| Mon, 01 Dec 2025 | €83.6b | €68.5b | €2.9b | 17.5x | 29x | 1.2x |
| Wed, 29 Oct 2025 | €79.3b | €68.8b | -€439,049,768.24 | 19.5x | -180.6x | 1.2x |
| Fri, 26 Sep 2025 | €75.9b | €68.8b | -€438,193,727.70 | 18x | -173.2x | 1.1x |
| Sun, 24 Aug 2025 | €79.9b | €68.9b | -€409,723,954.92 | 17.5x | -195.1x | 1.2x |
| Tue, 22 Jul 2025 | €77.7b | €69.4b | -€283,071,598.00 | 17.3x | -274.5x | 1.1x |
| Thu, 19 Jun 2025 | €76.9b | €69.4b | -€206,268,848.00 | 17.5x | -372.8x | 1.1x |
| Sat, 17 May 2025 | €74.7b | €69.4b | -€206,564,479.00 | 17.7x | -361.7x | 1.1x |
| Mon, 14 Apr 2025 | €72.5b | €69.3b | €467.0m | 17.7x | 155.2x | 1x |
| Wed, 12 Mar 2025 | €84.2b | €69.2b | €436.0m | 21x | 193.2x | 1.2x |
| Fri, 07 Feb 2025 | €85.4b | €69.2b | €2.0b | 22.9x | 42.1x | 1.2x |
| Sun, 05 Jan 2025 | €82.3b | €69.2b | €2.0b | 22.6x | 41x | 1.2x |
| Tue, 03 Dec 2024 | €83.1b | €69.2b | €2.0b | 21.1x | 41x | 1.2x |
| Thu, 31 Oct 2024 | €92.5b | €69.4b | €1.6b | 19.5x | 59.3x | 1.3x |
| Sat, 28 Sep 2024 | €102.1b | €69.4b | €1.5b | 24.6x | 69.3x | 1.5x |
| Mon, 26 Aug 2024 | €104.4b | €69.3b | €1.5b | 31.2x | 71.6x | 1.5x |
| Wed, 24 Jul 2024 | €95.4b | €69.2b | -€303,627,757.00 | 29.2x | -314.2x | 1.4x |
| Fri, 21 Jun 2024 | €100.6b | €69.2b | -€328,028,608.00 | 26.6x | -306.6x | 1.5x |
| Sun, 19 May 2024 | €103.4b | €69.2b | -€318,587,180.00 | 21.7x | -324.5x | 1.5x |
| Tue, 16 Apr 2024 | €94.6b | €70.0b | -€34,208,180.00 | 20.6x | -2764.1x | 1.4x |
| Thu, 14 Mar 2024 | €98.1b | €70.0b | €6.5m | 20.1x | 15100.7x | 1.4x |
| Sat, 10 Feb 2024 | €96.1b | €70.6b | -€650,504,143.00 | 19.8x | -147.8x | 1.4x |
| Mon, 08 Jan 2024 | €99.2b | €70.6b | -€650,504,143.00 | 20x | -152.5x | 1.4x |
| Wed, 06 Dec 2023 | €104.2b | €70.6b | -€650,606,256.00 | 18.9x | -160.2x | 1.5x |
| Fri, 03 Nov 2023 | €105.5b | €72.1b | €4.7b | 18x | 22.6x | 1.5x |
| Sun, 01 Oct 2023 | €116.1b | €72.1b | €4.7b | 22x | 24.8x | 1.6x |
| Tue, 29 Aug 2023 | €123.2b | €72.1b | €4.7b | 22.9x | 26.4x | 1.7x |
| Thu, 27 Jul 2023 | €122.3b | €74.1b | €6.5b | 18.9x | 19x | 1.6x |
| Sat, 24 Jun 2023 | €119.2b | €74.2b | €6.4b | 18.5x | 18.5x | 1.6x |
Price to Earnings Ratio
18.5x
Current Industry PE
- Investors are optimistic on the German Pharmaceuticals industry, and appear confident in long term growth rates.
- The industry is trading at a PE ratio of 200x which is higher than its 3-year average PE of 130x.
- The industry is trading close to its 3-year average PS ratio of 1.3x.
Past Earnings Growth
- The earnings for companies in the Pharmaceuticals industry have declined 58% per year over the last three years,
- Revenues have also declined 3.1% per year.
- This means overall sales from these companies are declining and profits are subsequently falling as well.
Industry Trends
Which industries have driven the changes within the German Healthcare industry?
| DE Market | 0.72% | |
| Healthcare | 0.0076% | |
| Pharma | -1.44% | |
| Pharma | -1.44% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| BAYN Bayer | €36.01 | 1.5% +€510.9m | 32.6% | PS0.8x | |
| DMP Dermapharm Holding | €48.15 | 4.0% +€91.7m | 37.4% | PE16.5x | |
| 27N0 Cannovum Cannabis | €0.45 | 11.1% +€104.0k | 142.5% | n/a |